Processing

Please wait...

Settings

Settings

Goto Application

1. WO2009004382 - 3-SPIROPYRIMIDINETRIONE-QUINOLINE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS

Publication Number WO/2009/004382
Publication Date 08.01.2009
International Application No. PCT/GB2008/050530
International Filing Date 01.07.2008
IPC
C07D 498/20 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
498Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
12in which the condensed system contains three hetero rings
20Spiro-condensed systems
A61K 31/5383 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
535having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
53751,4-Oxazines, e.g. morpholine
5383ortho- or peri-condensed with heterocyclic ring systems
C07F 7/10 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
FACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
7Compounds containing elements of Groups 4 or 14 of the Periodic System
02Silicon compounds
08Compounds having one or more C-Si linkages
10containing nitrogen
CPC
A61P 31/04
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
04Antibacterial agents
C07D 498/20
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
498Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
12in which the condensed system contains three hetero rings
20Spiro-condensed systems
C07F 7/0812
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
7Compounds containing elements of Groups 4 or 14 of the Periodic System
02Silicon compounds
08Compounds having one or more C—Si linkages
0803Compounds with Si-C or Si-Si linkages
081comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
0812comprising a heterocyclic ring
Applicants
  • ASTRAZENECA AB [SE]/[SE] (AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BE, BF, BG, BH, BJ, BR, BW, BY, BZ, CA, CF, CG, CH, CI, CM, CN, CO, CR, CU, CY, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, FR, GA, GB, GD, GE, GH, GM, GN, GQ, GR, GT, GW, HN, HR, HU, ID, IE, IL, IN, IS, IT, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MC, MD, ME, MK, ML, MN, MR, MT, MW, MX, MY, MZ, NA, NE, NG, NI, NL, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SI, SK, SL, SM, SN, SV, SY, SZ, TD, TG, TJ, TM, TN, TR, TT, TZ, UA, UG, UZ, VC, VN, ZA, ZM, ZW)
  • ASTRAZENECA UK LIMITED [GB]/[GB] (MG)
  • BASARAB, Gregory, Steven [US]/[US] (UsOnly)
  • DUMAS, Jacques [US]/[US] (UsOnly)
  • HILL, Pamela [US]/[US] (UsOnly)
Inventors
  • BASARAB, Gregory, Steven
  • DUMAS, Jacques
  • HILL, Pamela
Agents
  • ASTRAZENECA INTELLECTUAL PROPERTY
Priority Data
60/947,65402.07.2007US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) 3-SPIROPYRIMIDINETRIONE-QUINOLINE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS
(FR) COMPOSES CHIMIQUES
Abstract
(EN)
In one aspect, the present invention relates to compounds of Formula (I) and to pharmaceutically acceptable sa lts thereof, wherein: n is 1 to 4; and R3 in each occurrence is independently selected from -X-R5, -W-R6, -C(O)-N(R3a)-S(O)2-R3b, -C(R3a)=N-R3y, -C(R3a)=N-N(R3a)-C(O)-R3b, -C(R3a)=N-N(R3a)-C(O)2-R3b, -C(R3a)=N-N(R3y)2, -C(R3a)=N-N(R3a)-C(O)-N(R3y)2, -C(N(R3a)2)=N-R3y, -C(N(R3a)2)=N-OR3y, -C(N(R3a)2)=N-C(O)-R3b, -C(N(R3a)2=N-S(O)2-R3b, -C(N(R3a)2)=N-CN, -N=C(R3y)2, -N(R3a)-S(O)2-N(R3y)2, -N(R3a)-N(R3y)2, -N(R3a)-C(O)-N(R3y)2, -N(R3a)-C(O)-N(R3a)-S(O)2-R3b, -N(R3a)-C(R3a)=N(R3y), -N(R3a)-C(R3a)=N-OR3y, -N(R3a)-C(R3a) =N-C(O)-R3b, -N(R3a)-C(R3a)=N-S(O)2R-3b, -N(R3a)-C(R3a)=N-CN, -N(R3a)-C(N(R3a)2)=N-R3y, -N(R3a)-C(N(R3a)2)=N-OR3y, -N(R3a)-C(N(R3a)2)=N-C(O)-R3b, -N(R3a)-C(N(R3a)2)-N-S(O)2-R3b, -N(R3a)-C(N(R3a)2)-N-CN, -O-C(O)-R3b, and -Si(R3b)3; to methods of using them to treat bacterial infections, and to methods for their preparation.
(FR)
Dans un aspect, l'invention concerne des composés de formule (I) : (formule), des sels pharmaceutiquement acceptables de ceux-ci, ainsi que des méthodes d'utilisation de ces composés dans le traitement des infections bactériennes et des procédés de préparation associés.
Latest bibliographic data on file with the International Bureau